3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Vitamin D Deficiency
4
Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycystic Ovary Syndrome
2
Renal Insufficiency, Chronic
1
Myelodysplastic Syndromes
1
Multiple Sclerosis, Relapsing-Remitting
1
Hepatitis B, Chronic
1
Hepatitis B
1
Hematologic Diseases
1
Cardiovascular Diseases
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Bone Diseases, Metabolic
1
Anemia, Aplastic
1
Anemia
1
Interventions
sofosbuvir-velpatasvir drug combination
1
amlodipine, atorvastatin drug combination
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Rosuvastatin Calcium
1
Progesterone
1
Omeprazole
1
Naproxen
1
Liraglutide
1
Gonadotropin-Releasing Hormone
1
Geritol
1
Folic Acid
1
Febuxostat
1
Estradiol
1
Colchicine
1
Cholecalciferol
1
Chocolate
1
Atorvastatin
1
Antirheumatic Agents
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cardiovascular Diseases
×
Cholecalciferol
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled